Swixx Biopharma

Swixx Biopharma Expands to Latin America Through a Strategic Acquisition and Combination with Biopas 

With the addition of $220m in sales, over 300 employees and therapeutic coverage in Neurology, Oncology, Immunology, Gastroenterology, Rare Diseases and Specialty, acquisition extends and transforms Swixx BioPharma’s footprint The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies The acquisition builds on Swixx BioPharma’s rapid rate of organic growth;...
Neuhofstrasse 5A CH-6340 Baar Switzerland

+41 41 5523 440